Sinclair Pharma Regulatory News (SPH)

25 June 2014 Sinclair IS Pharma plc

Directors' Dealings

Sinclair IS Pharma plc (SPH.L), ("Sinclair" or the "Group") the international specialty pharma company, was informed on 24 June 2014 that earlier that day Stuart Swanson, a Non-Executive Director, acquired 900,000 ordinary shares in Sinclair at an average price of 32p per share. Following this purchase Stuart Swanson has a beneficial interest in 10,150,000 ordinary shares representing 2.04% of the Group's issued ordinary share capital. 

For further information, please contact:

Sinclair IS Pharma plc Tel: +44 (0) 20 7467 6920

Chris Spooner

Alan Olby

Robert Taylor

Peel Hunt LLP Tel: +44 (0) 20 7418 8900

James Steel

Clare Terlouw